Evidence map›Paper›PMID 37373897›Full record

ArticleJournal of personalized medicine2023

The Real Impact of Age on Mortality in Critically Ill COVID-19 Patients.

Agamemnon Bakakos, Evangelia Koukaki, Sevasti Ampelioti, Iliana Ioannidou, Andriana I Papaioannou, Konstantinos Loverdos, Antonia Koutsoukou, Nikoleta Rovina

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Agamemnon Bakakos1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-8933-6800
Evangelia Koukaki1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-9770-173X
Sevasti Ampelioti1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-1235-0182
Iliana Ioannidou1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Andriana I Papaioannou1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0001-9708-3241
Konstantinos Loverdos1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Antonia Koutsoukou1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Nikoleta Rovina1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-0138-5582
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe impact of severe infection from COVID-19 and the resulting need for life support in an ICU environment is a fact that caused immense pressure in healthcare systems around the globe. Accordingly, elderly people faced multiple challenges, especially after admission to the ICU. On this basis, we performed this study to assess the impact of age on COVID-19 mortality in critically ill patients. MATERIALS AND

methodsIn this retrospective study, we collected data from 300 patients who were hospitalized in the ICU of a Greek respiratory hospital. We split patients into two age groups using a threshold of 65 years old. The primary objective of the study was the survival of patients in a follow up period of 60 days after their admission to the ICU. Secondary objectives were to determine whether mortality is affected by other factors, including sepsis and clinical and laboratory factors, Charlson Comorbidity Index (CCI), APACHE II and d-dimers, CRP, etc. Results: The survival of all patients in the ICU was 75.7%. Those in the <65 years old age group expressed a survival rate of 89.3%, whereas those in the ≥65 years old age group had a survival rate of 58% (

conclusionsAge alone as a simple number is not capable of predicting mortality in patients with severe COVID-19 in the ICU. We must use more composite clinical markers that may better reflect the biological age of patients, such as CCI. Moreover, the effective control of infections in the ICU is of utmost importance for the survival of patients, since avoiding septic complications can drastically improve the prognosis of all patients, regardless of age.

Indexed as

ageCOVID-19elderlyICUrespiratory failureSARS-CoV-2

Identifiers

PMID37373897
PMCPMC10303099
OpenAlexW4378717125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.